Ritesh R. Kotecha - Concepedia

Author

Ritesh R. Kotecha

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Kotecha, Ritesh R, Kotecha, Ritesh R., R Kotecha, R. Kotecha, R.R. Kotecha, Ritesh Kotecha, Ritesh R Kotecha, Ritesh R. Kotecha

215

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University The University of Texas MD Anderson Cancer Center Cleveland Clinic Molecular Oncology (United States)

About

Ritesh R. Kotecha is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	524
2	Health Sciences	3	3	86
3	Engineering	1	1	40
4	Anatomy	1	1	40
5	Biomedical Engineering	1	1	40

Ritesh R. Kotecha

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates Chung‐Han Lee, Martin H. Voss, Maria I. Carlo, Journal of Clinical Oncology	2022	182
Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma Mattias Carlsten, Neha Korde, Ritesh R. Kotecha, Clinical Cancer Research	2016	162
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors Amishi Y. Shah, Ritesh R. Kotecha, Emily Lemke, European Journal of Cancer UrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorCancer Treatment	2019	120
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma Jack P. Gleeson, Ines Nikolovski, Renzo G. DiNatale, Clinical Cancer Research	2021	84
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine Ramin S. Herati, David A. Knorr, Laura A. Vella, Nature Immunology VaccinationSeasonal Influenza VaccineHumoral Immune ResponsesHumoral ResponseImmunology	2022	73
Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy Maria I. Carlo, Kyrollis Attalla, Yousef Mazaheri, European Urology UrologySurgical OncologyGenitourinary CancerKidney ResearchMedicine	2022	61
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression Julian Marcon, Renzo G. DiNatale, Alejandro Sánchez, Clinical Cancer Research	2020	52
DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy Yasser Ged, Joshua Chaim, Renzo G. DiNatale, Journal for ImmunoTherapy of Cancer	2020	50
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape Mahdi Golkaram, Fengshen Kuo, Sounak Gupta, Genome Medicine	2022	44
Unbiased Pathogen Detection and Host Gene Profiling for Conjunctivitis Prajna Lalitha, Gerami D. Seitzman, Ritesh R. Kotecha, Ophthalmology Pathogen DetectionPathogenesisHost Gene ProfilingPathogen CharacterizationMicrobiology	2019	41

Page 1